| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02570506 |
| P8608 | Fatcat ID | release_dcya6tj4vjaxdlblbb6cxpjjve |
| P698 | PubMed publication ID | 7867679 |
| P2093 | author name string | J F O'Hanlon | |
| J G Ramaekers | |||
| P2860 | cites work | Effects of terfenadine and diphenhydramine alone or in combination with diazepam or alcohol on psychomotor performance and subjective feelings | Q39233047 |
| The effects of acrivastine (BW825C), diphenhydramine and terfenadine in combination with alcohol on human CNS performance | Q48257498 | ||
| Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. | Q49151757 | ||
| The effects of terfenadine with and without alcohol on an aspect of car driving performance | Q50120062 | ||
| The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects. | Q50803636 | ||
| Diazepam impairs lateral position control in highway driving. | Q51860313 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 261-266 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing | |
| P478 | volume | 47 |
| Q46713303 | A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance |
| Q44634862 | A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis. |
| Q34139004 | Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers. |
| Q36511605 | Aging and nocturnal driving: better with coffee or a nap? A randomized study |
| Q40483823 | Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989‐94 |
| Q35720124 | Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic |
| Q33709795 | Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects |
| Q40914207 | Can the MSLT be a useful tool to assess motor vehicle crash risk in sleepy drivers? |
| Q40964619 | Cognitive impairment in elderly people. Predisposing factors and implications for experimental drug studies. |
| Q35884188 | Comparing treatment effects of oral THC on simulated and on-the-road driving performance: testing the validity of driving simulator drug research |
| Q35627751 | Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials |
| Q53943851 | Development of terfenadine-pseudoephedrine double-layer tablet dissolution-equivalent to core tablet. |
| Q44423339 | Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial |
| Q46818265 | Effects of a sedative antihistamine, D-chlorpheniramine, on regional cerebral perfusion and performance during simulated car driving |
| Q40154364 | Effects of alcohol on automated and controlled driving performances. |
| Q38174544 | Effects of central nervous system drugs on driving: speed variability versus standard deviation of lateral position as outcome measure of the on-the-road driving test |
| Q43956688 | Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females |
| Q95656868 | Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls |
| Q49151757 | Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. |
| Q36091036 | Effects of stimulant drugs on actual and simulated driving: perspectives from four experimental studies conducted as part of the DRUID research consortium |
| Q52856889 | Evaluating the effects of bilingual traffic signs on driver performance and safety. |
| Q33378468 | Extended driving impairs nocturnal driving performances |
| Q37230876 | Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance |
| Q46798714 | Histamine H1-receptor blockade in humans affects psychomotor performance but not memory |
| Q34456232 | In-car nocturnal blue light exposure improves motorway driving: a randomized controlled trial |
| Q34385380 | Intranasal corticosteroids for allergic rhinitis: superior relief? |
| Q48427182 | Maintenance of Wakefulness Test, obstructive sleep apnea syndrome, and driving risk |
| Q48458471 | Marijuana, alcohol and actual driving performance |
| Q39886402 | Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trial |
| Q33709789 | Non-cardiac adverse effects of antihistamines (H1-receptor antagonists). |
| Q44147910 | Of injuries and antihistamines and dosing |
| Q33810643 | On-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics |
| Q39430561 | Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge |
| Q28289605 | Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance |
| Q33810623 | Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study. |
| Q73744830 | Seasonal allergic rhinitis and cognitive function |
| Q34982550 | Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios |
| Q44409442 | Sedation and performance impairment of diphenhydramine and second-generation antihistamines: A meta-analysis |
| Q40845437 | Slow eyelid closure as a measure of driver drowsiness and its relationship to performance. |
| Q48875721 | The eternal triangle: benefit, risk, and cost of therapeutic agents |
| Q36493193 | The interactive effects of extended wakefulness and low-dose alcohol on simulated driving and vigilance |
| Q48093193 | The role of P-glycoprotein in CNS antihistamine effects |
| Q37856874 | What to do with refractory urticaria patients |
Search more.